Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China flag China · Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST

Shanghai Pharmaceuticals Holding Statistics

Total Valuation

Shanghai Pharmaceuticals Holding has a market cap or net worth of CNY 69.28 billion. The enterprise value is 95.44 billion.

Market Cap 69.28B
Enterprise Value 95.44B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date Oct 28, 2024
Ex-Dividend Date Sep 24, 2024

Share Statistics

Shanghai Pharmaceuticals Holding has 3.70 billion shares outstanding. The number of shares has decreased by -0.83% in one year.

Current Share Class n/a
Shares Outstanding 3.70B
Shares Change (YoY) -0.83%
Shares Change (QoQ) +0.46%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 14.37%
Float 1.83B

Valuation Ratios

The trailing PE ratio is 19.36 and the forward PE ratio is 15.39. Shanghai Pharmaceuticals Holding's PEG ratio is 1.04.

PE Ratio 19.36
Forward PE 15.39
PS Ratio 0.29
PB Ratio 1.09
P/TBV Ratio n/a
P/FCF Ratio 24.28
P/OCF Ratio n/a
PEG Ratio 1.04
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 29.91.

EV / Earnings 23.71
EV / Sales 0.35
EV / EBITDA 9.26
EV / EBIT 11.34
EV / FCF 29.91

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.68.

Current Ratio 1.34
Quick Ratio 1.02
Debt / Equity 0.68
Debt / EBITDA 5.46
Debt / FCF 17.63
Interest Coverage 4.65

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.86%.

Return on Equity (ROE) 6.41%
Return on Assets (ROA) 2.41%
Return on Capital (ROIC) 3.86%
Revenue Per Employee 5.66M
Profits Per Employee 83,577
Employee Count 48,164
Asset Turnover 1.25
Inventory Turnover 6.67

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.22% in the last 52 weeks. The beta is 0.30, so Shanghai Pharmaceuticals Holding's price volatility has been lower than the market average.

Beta (5Y) 0.30
52-Week Price Change +16.22%
50-Day Moving Average 19.79
200-Day Moving Average 18.59
Relative Strength Index (RSI) 58.82
Average Volume (20 Days) 26,385,017

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Shanghai Pharmaceuticals Holding had revenue of CNY 272.42 billion and earned 4.03 billion in profits. Earnings per share was 1.08.

Revenue 272.42B
Gross Profit 30.14B
Operating Income 8.42B
Pretax Income 7.18B
Net Income 4.03B
EBITDA 9.62B
EBIT 8.42B
Earnings Per Share (EPS) 1.08
Full Income Statement

Balance Sheet

The company has 42.39 billion in cash and 56.25 billion in debt, giving a net cash position of -13.87 billion or -3.74 per share.

Cash & Cash Equivalents 42.39B
Total Debt 56.25B
Net Cash -13.87B
Net Cash Per Share -3.74
Equity (Book Value) 83.16B
Book Value Per Share 19.13
Working Capital 44.26B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.71 billion and capital expenditures -2.52 billion, giving a free cash flow of 3.19 billion.

Operating Cash Flow 5.71B
Capital Expenditures -2.52B
Free Cash Flow 3.19B
FCF Per Share 0.86
Full Cash Flow Statement

Margins

Gross margin is 11.07%, with operating and profit margins of 3.09% and 1.48%.

Gross Margin 11.07%
Operating Margin 3.09%
Pretax Margin 2.64%
Profit Margin 1.48%
EBITDA Margin 3.53%
EBIT Margin 3.09%
FCF Margin 1.17%

Dividends & Yields

This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 1.94%.

Dividend Per Share 0.41
Dividend Yield 1.94%
Dividend Growth (YoY) -19.67%
Years of Dividend Growth 1
Payout Ratio 85.84%
Buyback Yield 0.83%
Shareholder Yield 2.77%
Earnings Yield 5.17%
FCF Yield 4.12%
Dividend Details

Stock Splits

The last stock split was on August 16, 2007. It was a forward split with a ratio of 1.2.

Last Split Date Aug 16, 2007
Split Type Forward
Split Ratio 1.2

Scores

Shanghai Pharmaceuticals Holding has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.08
Piotroski F-Score n/a